News Industry News Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds November 21, 2016
News Industry News Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) September 20, 2016
News Industry News EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval August 15, 2016
News Industry News Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial June 17, 2016
News Industry News Secondary Analysis of EXAMINE Trial Finds Highest Risk of Cardiovascular Death for Patients Previously Hospitalized with Heart Failure June 13, 2016
News Industry News St. Jude Medical Announces Launch and First US Implants of MultiPoint Pacing Technology April 18, 2016
News Industry News St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations April 04, 2016
News Industry News TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI February 17, 2016
News Industry News Meta-Analysis Shows Medtronic's Solitaire(TM) Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+ February 17, 2016
News Industry News New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016 February 08, 2016
News Industry News Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock December 15, 2015
News Industry News TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI November 04, 2015
News Industry News Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year October 15, 2015
News Industry News Medtronic Launches Arc(TM) Support Catheter Series in U.S. for Treatment of Acute Ischemic Stroke September 17, 2015
News Industry News Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints September 16, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015